The Science Behind Tetrasil

 

What is Tetrasil?

Tetrasil® is a powerful multi-purpose topical ointment. Customers worldwide have used it for the treatment of a wide range of skin conditions. Tetrasil's key ingredient, Tetrasilver Tetroxide (TST™), has a natural attraction to the surface of bacteria, fungi and viruses. These pathogens are responsible for the itching, rashes, redness, burning and other unwanted symptoms of the skin conditions. Upon contact, TST's unique chemical structure releases both a micro electrical charge and oxygen, which immediately begins to kill the pathogens. Customers say the result is not just rapid relief, but elimination of the root cause. Tetrasil® is protected by US and international patents, with additional patents pending.

Chemistry

Tetrasil® contains Tetrasilver Tetroxide (TST™), suspended in an ointment base (organic wax, Jojoba oil). TST™ is a small inorganic, semi-conducting molecular crystal that contains two monovalent and two trivalent silver ions that are electrically balanced by four oxygen ions. The chemical formula for TST™ is Ag4O4. Unlike colloidal silver, which is just a single silver ion, TST™ is a multi-valent molecule with a naturally occurring electrical potential many times more powerful than colloidal silver. Further, unlike colloidal silver, TST™ does not bind with healthy tissue.

Mechanism of Action

Theoretical depiction at microbial level:

1. ATTRACTION

Illustrated above is a virus (large ball formation) in the early stages of attack by an array of TST™ molecules (small blue particles). Within minutes of application, millions of TST™ molecules are strongly attracted to and react with the harmful microorganisms.

2. CONTACT & ELECTRICAL SHOCK

Upon contact of each TST™ molecule with the pathogen’s surface chemicals, the TST™ molecule releases a micro electrical charge. This electrical shock, it is theorized, destroys the ability of the pathogen’s ability to process information and survive.

3. CHEMICAL BINDING, OXYGEN
RELEASE & MICROBIAL DEATH

The TST™ molecules then bond, chemically, with the pathogen, in a process known as a “redox” reaction. As a result, the microbe dies from the metallic bonding and electrical bombardment. Furthermore, oxygen is released, providing additional benefits for healthy cells nearby.

In-vitro Laboratory Testing

An extensive battery of testing on TST™ with renown Contract Research Organizations (CROs) has been performed. The results are quite compelling results. See links below:

EPA Safety Data on TST™

The US Environmental Protection Agency (EPA) directed a study of TST™ and awarded it a Category 4 designation (their highest safety rating) as a powerful anti-microbial (for use in swimming pools and spas) after a battery of oral, dermal and ocular toxicity tests. See EPA Registration No. 3432-64. Trials were conducted between the EPA and Antelman Technologies, then licensed to a third-party company for manufacturing and marketing rights. Note: The US Food & Drug Administration (FDA) has not yet reviewed or approved TST™ for therapeutic use.

Manufacturing and Handling

Procedures and quality controls have been developed and established to ensure that the supply and proper handling of Tetrasil® is consistently manufactured to strict standards, following US Food & Drug Administration Good Manufacturing Procedure (GMP) guidelines in GMP-registered facilities.

In-vitro Laboratory Testing Table
 

The following table presents the Minimum Inhibitory Concentration (MIC), in parts per million, of TST required to destroy the pathogens shown. Source: Aidance Skincare & Topical Solutions, LLC. All tests were stated to have been "performed by recognized contract research organizations at FDA-certified laboratories."

 

Microorganism

Minimum Lethal Concentration
Parts-Per-Million

 Gram Negative Bacteria
  Escherichia coli 10231 2.50
  Escherichia coli 25254 2.50
  Enterobacter cloacae 13047 2.50
  Pseudomonas aeruginosa 9027 1.25-2.50
  Salmonella < 2
 Gram Positive Bacteria
  Bacillus Anthracis (Anthrax) < 70.00
  Bacillus subtilis 6633 5.00
  Micrococcus lutena 9341 1.25-2.50
  Staphylococcus aureus 0927 2.50-5.00
  Staphylococcus aureus 27543 5.00
  Staphylococcus epidermidis 12228 0.625
  Streptococcus agalactiae 27956 1.25-5.00
  Streptococcus faecium 10541 5.00
  Streptococcus pyogenes 7958 2.50
  Streptococcus faecalis 0.50
 Antibiotic–Resistant* and Susceptible Bacteria
  E. coli 32.00
  S. aureus 32.00
  K. pneumoniae 16.00
  S. agalactiae (Group B) 32.00
  P. aeruginosa 16.00
  S. pyogenes 16.00
  E. faecalis ATCC 29212 * 32.00
  E. faecium ATCC 700221 * 16.00
 
* Vancomycin-resistant
 
 Yeast and Mold
  Candida albicans 16404 2.50-5.00
  Saccharomyces cerevisiae 2601 1.25
 Viruses
  Herpes Simplex- HSV-1, HSV-2 < 96.00

 

 

 


© 2003-2007 MySkinCure.com is a Registered Affiliate promoting Aidance Skincare products.
TETRASIL® and TST Molecules InsideTM are registered trademarks of Aidance Skincare & Topical Solutions, LLC.
Tetrasil is protected by US and international patents granted and pending.

A key ingredient in Tetrasil®, Tetrasilver Tetroxide (TsT), was originally developed for and approved by the U.S. EPA
 as safe, non-toxic and effective in destroying a wide variety of pathogens commonly found in swimming pools,
Neither Tetrasil® nor TsT have been evaluated or approved by the U.S. Food & Drug Administration (FDA).
Tetrasil® is not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease.
Tetrasil® is not intended to affect the structure or any function of the body of man or other animals.
Tetrasil® is intended for the cleansing, beautifying and moisturizing of the human body.